CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570)
Spinifex Pharmaceuticals is a US-Australian biotechnology company developing new drug candidates for the treatment and management of pain. Established in 2005 and based in Stamford, Connecticut and Melbourne, Australia, Spinifex has applied its world...Show all
Company (Acquired)
Phone: +61 (0)3 9863 6820
Corporate One
Suite G5, 84 Hotham St
Preston, 3072
Victoria, Australia
| Total Funding | Date of Last Funding | |
|---|---|---|
| Spinifex | $75.2M | Jun 29, 2015 |
| Cara Therapeutics | $113M | Jan 31, 2014 |
| Celera Genomics | $0M | May 17, 2011 |
| See all 14 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Heterocyclic compounds and methods for their use | Jan 25, 2013 | Apr 18, 2017 | Patent |
| Heterocyclic compounds and methods of their use | Jan 04, 2013 | Apr 18, 2017 | Patent |
| Method of treatment or prophylaxis of inflammatory pain | Sep 03, 2013 | Jan 05, 2016 | Patent |
| Salts and solvates of a tetrahydroisoquinoline derivative | Dec 17, 2014 | Oct 20, 2015 | Patent |
| Methods and compositions for improved nerve conduction velocity | Jan 19, 2011 | Aug 04, 2015 | Patent |
